Musiccosmos

Europe’s counterpart to the US Food and Drug Administration is temporarily scaling back activities as it anticipates greater-than-expected loss of staff when it relocates due to Brexit. The European Medicines Agency said Wednesday that it would scale back or suspend certain activities through next year so that it can focus on evaluating and supervising medicines ahead of a planned move from its current home in London to Amsterdam, set to take place by the date Brexit occurs, on March 30, 2019. The cutbacks will take place on Oct. 1 “at the latest.” The EMA will cut back international collaboration in areas like harmonizing global regulations, in which the agency said it will take only a reactive role. On issues like antimicrobial resistance and vaccines, it will maintain activities “as long as possible,” but review them on a case-by-case basis. Clinical data publication, development and revision of guidelines, working parties not related to products and other activities will be s...